Will TherapeuticsMD Inc. (NYSE MKT:TXMD) explode?


How far has the stock of TherapeuticsMD, Inc. (NASDAQ:TXMD) come to trade at their current price of $4.18, which gives it a market cap of $886.41M.

To trade now at $4.18, the stock has emerged from a 52-week low of $-3.24%. But the current price also compares with the 52-week peak of $-55.01%.

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

Recently, TherapeuticsMD, Inc. (NASDAQ:TXMD) announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for TX-004HR, the company’s investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause.

The stock’s journey to the current price can be understood by looking at its performance from the last week down to the 12 months. The stock?s weekly performance stands at -16.57% and its monthly performance is -48.33%. For the quarter, the stock has moved -28.30% and for half-year it has shifted -11.44%. So far this year the stock has moved -46.06%% and for the last 12 months it has moved -27.56%.

Studying simple moving averages also tell the stock’s journey thus far. The 20-Day Simple Moving Average is $-20.06%, the 50-Day Simple Moving Average is $-32.60%, while the 200-Day Simple Moving Average is $-34.24%.